Subscribe to RSS
DOI: 10.1055/s-0044-101834
Thyroid-Stimulating Hormone-Stimulated Human Adipocytes Express Thymic Stromal Lymphopoietin
Publication History
received 17 July 2017
accepted 23 January 2018
Publication Date:
19 February 2018 (online)
Abstract
When recombinant human (rh) thyroid-stimulating hormone (TSH) is administered to thyroid cancer survivors, an acute extra-thyroidal effect raises pro-inflammatory cytokines and activates platelets. Thymic stromal lymphopoietin (TSLP) is a cytokine recently implicated in platelet activation. Our aim was to measure platelet microparticle levels after rhTSH stimulation in vivo, and to investigate TSLP expression in TSH-stimulated human adipocytes in culture. Blood samples for total and platelet microparticle analysis were obtained from thyroid cancer survivors before (day 1) and after rhTSH administration (day 5). Adipocytes, differentiated from stromal preadipocytes isolated from adipose tissue from surgical patients, were stimulated with TSH. TSLP mRNA expression, protein expression, and protein release into the adipocyte medium were measured. The level of platelet microparticles in thyroid cancer patients rose 5-fold after rhTSH stimulation. TSH upregulated TSLP mRNA expression in adipocytes in culture through a pathway that was inhibited by 66% by H89, a protein kinase A inhibitor. TSLP protein expression rose in response to TSH, and TSH-stimulated TSLP release into the medium was completely blocked by dexamethasone. In conclusion, TSLP is a novel TSH-responsive adipokine. Future studies will be needed to address the potential role of adipocyte-derived TSLP and whether it is linked to TSH-dependent platelet activation.
-
References
- 1 Park JH, Jeong DY, Peyrin-Biroulet L, Eisenhut M, Shin JI. Insight into the role of TSLP in inflammatory bowel diseases. Autoimmun Rev 2017; 16: 55-63
- 2 Turcot V, Bouchard L, Faucher G, Garneau V, Tchernof A, Deshaies Y, Perusse L, Marceau S, Biron S, Lescelleur O, Biertho L, Vohl MC. Thymic stromal lymphopoietin: An immune cytokine gene associated with the metabolic syndrome and blood pressure in severe obesity. Clin Sci 2012; 123: 99-109
- 3 Mao Y, Peng Y, Zeng Q, Cheng L, Wang B, Mao X, Meng K, Liu Y, Lian Y, Li D. A potential mechanism of high-dose ticagrelor in modulating platelet activity and atherosclerosis mediated by thymic stromal lymphopoietin receptor. PLoS One 2015; 10: e0141464
- 4 Marcus C, Ehrén H, Bolme P, Arner P. Regulation of lipolysis during the neonatal period. Importance of thyrotropin. J Clin Invest 1988; 82: 1793-1797
- 5 Menendez C, Baldelli R, Camina JP, Escudero B, Peino R, Dieguez C, Casanueva FF. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol 2003; 176: 7-12
- 6 Antunes TT, Gagnon A, Langille ML, Sorisky A. Thyroid-stimulating hormone induces interleukin-6 release from human adipocytes through activation of the nuclear factor-kB pathway. Endocrinology 2008; 149: 3062-3066
- 7 Gagnon A, Langille ML, Chaker S, Antunes TT, Durand J, Sorisky A. TSH signaling pathways that regulate MCP-1 in human differentiated adipocytes. Metabolism 2014; 63: 812-821
- 8 Gagnon A, Antunes TT, Ly T, Pongsuwan P, Gavin C, Lochnan HA, Sorisky A. TSH-stimulates lipolysis in adipocytes in culture and raises serum free fatty acid levels in vivo. Metabolism 2010; 59: 547-553
- 9 Antunes TT, Gagnon A, Chen B, Pacini F, Smith TJ, Sorisky A. Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: Effect of adipocyte differentiation and anatomic depot. Am J Physiol Endocrinol Metab 2006; 290: E1140-E1144
- 10 Santini F, Galli G, Maffei M, Fierabracci P, Pelosini C, Marsili A, Giannetti M, Castagna MG, Checchi S, Molinaro E, Piaggi P, Pacini F, Elisei R, Vitti P, Pinchera A. Acute exogenous TSH administration stimulates leptin secretion in vivo. Eur J Endocrinol 2010; 163: 63-67
- 11 Dardano A, Ghiadoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, Taddei S, Ferrannini E, Salvetti A, Monzani F. Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006; 91: 4175-4178
- 12 Desideri G, Bocale R, Milardi D, Ghiadoni L, Grassi D, Necozione S, Taddei S, di Orio F, Pontecorvi A, Ferri C. Enhanced proatherogenic inflammation after recombinant human TSH administration in patients monitored for thyroid cancer remnant. Clin Endocrinol 2009; 71: 429-433
- 13 Burger D, Gagnon A, Lochnan HA, Mahzari M, Sorisky A. Thyroid-stimulating hormone acutely increases levels of circulating pro-coagulant microparticles. Clinical Endocrinol 2015; 83: 285-287
- 14 Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM. Microparticles: Biomarkers and beyond. Clinical Sci 2013; 124: 423-441
- 15 Gagnon A, Ooi TC, Cousins M, Favreau C, Henry K, Landry A, Sorisky A. The anti-adipogenic effect of peripheral blood mononuclear cells is absent with PCSK9 loss-of-function variants. Obesity 2016; 24: 2384-2391
- 16 Gagnon A, Yarmo MN, Landry A, Sorisky A. Macrophages alter the differentiation-dependent decreases in fibronectin and collagen I/III protein levels in human preadipocytes. Lipids 2012; 47: 873-880
- 17 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
- 18 Scherer PE. The multifaceted roles of adipose tissue-therapeutic targets for diabetes and beyond: The 2015 Banting lecture. Diabetes 2016; 65: 1452-1461
- 19 Cultrone A, de Wouters T, Lakhdari O, Kelly D, Mulder I, Logan E, Lapaque N, Dore J, Blottiere HM. The NF-kappaB binding site located in the proximal region of the TSLP promoter is critical for TSLP modulation in human intestinal epithelial cells. Eur J Immunol 2013; 43: 1053-1062
- 20 Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, Li M, Chambon P. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011; 145: 224-241
- 21 Hudson WH, Youn C, Ortlund EA. The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol 2013; 20: 53-58
- 22 Lupoli R, Di Minno MN, Tortora A, Scaravilli A, Cacciapuoti M, Barba L, Di Minno A, Ambrosino P, Lupoli GA, Lupoli G. Primary and secondary hemostasis in patients with subclinical hypothyroidism: Effect of levothyroxine treatment. J Clin Endocrinol Metab 2015; 100: 2659-2665